Buy generic drugs from our online pharmacy without prescription

0
You have no items in your shopping cart.

0

Welcome to our online store!

Buy Trecator-SC online without prescription

Quick Overview

Trecator-SC is used to treat tuberculosis in combination with other drugs.

Availability:
in stock
Product #:
000159
Active ingredient:
Ethionamide
Available Dosage:
250 mg;
Do I need a prescription?:
No, when purchased online
Payment options:
VISA, Mastercard, American Express, Diners Club, Jcb card and cryptocurrency (Bitcoin, Ethereum)
Delivery time:
Trackable Courier Service, 5-9 days, International Unregistered Mail, 14-21 days
Delivery to countries:
worldwide, including United Kingdom, Australia and USA

Trecator-SC 250 mg Price

Package Price Per Pill  
30 pills x 250 mg $ 51.99 $ 1.73
60 pills x 250 mg $ 82.99 $ 1.38
90 pills x 250 mg $ 111.99 $ 1.24
120 pills x 250 mg $ 134.99 $ 1.12
180 pills x 250 mg $ 181.99 $ 1.01

Product information

Trecator-SC is effective to control the spread of tuberculosis to humans. In addition Trecator-SC is used as a treatment for tuberculosis of the skin in combination with other drugs such as metronidazole, carboplatin, aminoglycoside (A) or metronidazole-sulfonic acid (MSSA) to control inflammation of the skin and to reduce the growth of tuberculosis in the skin. Trecator is available as a single drug or in a tablet or gel, and is used in combination with drugs such as aminoglycoside or metronidazole to control growth of tuberculosis in the skin. Trecator is available as a single drug or in a tablet or gel, and is used in combination with drugs such as aminoglycoside or metronidazole to control growth of tuberculosis in the skin. Tricetasol (Citral) is a selective anti-tuberculosis agent which is used for the treatment of tuberculosis infection of the skin and the treatment of tuberculosis of the lungs. Cital was approved in 1999 and in 2004 was approved for tuberculosis treatment of the lungs in combination with cimetidine. Dry powder: Trecator-SC can be administered as dry powder or in a solution of 50% to 70% (v/v) dry trecator-SC (Tritan-SC). Dosage: 100-150 mg (3 mL) per day. Inhalation: Take one capsule twice daily at the end of inhalation. Dosage: 200 to 500 mg (1-2 mL), orally. Dosage: 200-500 mg (1-2 mL) per day. Inhalation: Take one capsule every three hours, at the beginning of each day. Dosage: 500 mg, orally. Dosage: 100 to 200 mg (6-8 mL) per day. Inhalation: Take three (or less) capsules every three hours, at the beginning of each day. Dosage: 200 mg (3 mL) every four (or less) hours. Treat symptoms Doses of trecator-SC are as follows: Tremor: 100 mg (3 mL) per day Leprosy This study was conducted at the University of Minnesota Medical School (University of Minnesota-Health Sciences Center). The participants were volunteers recruited from various areas (state and federal) who had recently received TcSC from the manufacturer and were receiving it for the first time on a monthly basis. The patients were enrolled into the study because they were not previously receiving TcSC and the treatment group was not aware of any adverse effects of TcSC. The TcSC was given intravenously for the treatment of chronic tuberculosis at the University of Minnesota. TcSC was administered for 2 months on a monthly basis. The study was approved by the institutional review board of the University of Minnesota. This was a double blind, placebo controlled trial. The primary outcome was the incidence of acute tuberculosis in a population defined as having one or more active tuberculosis patients (those with at least 4 active cases of active tuberculosis at the time of the study). The secondary outcome was the number of active tuberculosis cases diagnosed by a clinician at enrollment (as defined by the Centers for Disease Control and Prevention). TbSC has been approved by the U.S. Food and Drug Administration (FDA) for use in combination with the drug tacrolim It is also used against tuberculosis in combination with other drugs. This is the main class of antibiotics against tuberculosis that is used against the infection of patients. It is a drug that can be used for treatment of the acute disease. This medication can be used at home in combination with other antibiotics and also for other treatment in the future. Trecator-SC is usually given on a prescription or in the hospital. It can be prescribed in combination with other drugs in combination with Trecator-SC. Tricorder-SC is used to treat a wide range of diseases. It is usually given on a prescription or in the hospital. This class of antibiotics are mainly used against tuberculosis in combination with other drugs. The class of anti-Treg cells includes the class of anti-Treg cells that are involved in the immune response against bacterial infections like tuberculosis and other infectious diseases and in suppressing the growth of mycobacteria. This class of anti-Treg cells is called the anti-Treg cell class. Trecator, the main class of anti-Treg cells, is the active ingredient of this class, used for It is effective in combination with anti-tuberculosis medications. Trecator-SC inhibits tuberculosis's growth at the periphery (in vitro, cell culture) and at the center (in vivo, in vivo). Trecator-SC inhibits the growth of the Mycobacterium tuberculosis in the culture medium and inhibits its development at the periphery. In the last 10 years, Trecator-SC has become the first antibiotic that has been approved by the FDA to treat human tuberculosis infection. It was approved to treat human tuberculosis in the U. in 2007. It was used in clinical trials in 2005 and in 2008, and is now FDA-approved as a treatment for tuberculosis. It is also approved to treat human tuberculosis as an experimental treatment to treat patients with acute respiratory distress syndrome, tuberculosis-associated pulmonary hypertension, and pneumonia with pulmonary tuberculosis, which is a rare, chronic disease of the lung. In addition, in clinical trials, Trecator-SC was shown to be effective against acute respiratory infections in the United States as well as the European Union. The FDA has issued a provisional approval letter to Trecator-SC in September of 2012. This approval is not final, and is being reviewed by the FDA Advisory Committee on Immunization Practices (ACIP). The ACIP is a panel made up of health authorities, including FDA, and physicians. The Committee has not yet decided on Trecator-SC for use in the U., and will likely make a decision at this time as to whether or not Trecator-SC Dosage: Dosage of Trecator-SC is in mg/kg, daily dosage. Trecator-SC should be taken in combination with other antibiotics. Precaution: The drug is contraindicated in patients with chronic diseases and those with impaired immune system functioning. In case of severe or severe infection, the use of the drug is contraindicated.
More info loading...